Stock Track | Clover Bio-B Plummets 5.32% Intraday After Annual Results Show 90.9% Revenue Drop

Stock Track03-26

Clover Bio-B shares plummeted 5.32% during the intraday session on Thursday, following the release of the company's annual financial results which revealed a dramatic decline in revenue.

The biopharmaceutical company reported that its revenue for FY2025 dropped 90.9% to just RMB 3.5 million, primarily due to the termination of AdimFlu-S commercial activities in mainland China. The remaining revenue reflects a return-rate true-up on prior-period sales.

While the company's loss for the year narrowed by 77.3% to RMB 205.1 million, investors appeared focused on the severe revenue contraction and the 51.23% decline in cash and bank balances to RMB 271.4 million, attributed to bank-loan repayment, continued R&D investment, and daily operations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1196931301?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-26 09:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196931301","market":"hk","top_or_hot":-1,"title":"Stock Track | Clover Bio-B Plummets 5.32% Intraday After Annual Results Show 90.9% Revenue Drop","media":"Stock Track","content":"<p>Clover Bio-B shares plummeted 5.32% during the intraday session on Thursday, following the release of the company's annual financial results which revealed a dramatic decline in revenue.</p>\n<p>The biopharmaceutical company reported that its revenue for FY2025 dropped 90.9% to just RMB 3.5 million, primarily due to the termination of AdimFlu-S commercial activities in mainland China. The remaining revenue reflects a return-rate true-up on prior-period sales.</p>\n<p>While the company's loss for the year narrowed by 77.3% to RMB 205.1 million, investors appeared focused on the severe revenue contraction and the 51.23% decline in cash and bank balances to RMB 271.4 million, attributed to bank-loan repayment, continued R&D investment, and daily operations.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Clover Bio-B Plummets 5.32% Intraday After Annual Results Show 90.9% Revenue Drop</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Clover Bio-B Plummets 5.32% Intraday After Annual Results Show 90.9% Revenue Drop\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-26 09:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Clover Bio-B shares plummeted 5.32% during the intraday session on Thursday, following the release of the company's annual financial results which revealed a dramatic decline in revenue.</p>\n<p>The biopharmaceutical company reported that its revenue for FY2025 dropped 90.9% to just RMB 3.5 million, primarily due to the termination of AdimFlu-S commercial activities in mainland China. The remaining revenue reflects a return-rate true-up on prior-period sales.</p>\n<p>While the company's loss for the year narrowed by 77.3% to RMB 205.1 million, investors appeared focused on the severe revenue contraction and the 51.23% decline in cash and bank balances to RMB 271.4 million, attributed to bank-loan repayment, continued R&D investment, and daily operations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02197","symbol_name":"三叶草生物-B","start_time":0,"source_url":"","article_id":"1196931301","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196931301","pubTimestamp":1774488854,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Clover Bio-B shares plummeted 5.32% during the intraday session on Thursday, following the release of the company's annual financial results which revealed a dramatic decline in revenue. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02197":"三叶草生物-B"},"translate_title":"个股追踪|三叶草生物-B盘中暴跌5.32%，此前全年业绩显示营收大降90.9%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02197":1},"content_text":"Clover Bio-B shares plummeted 5.32% during the intraday session on Thursday, following the release of the company's annual financial results which revealed a dramatic decline in revenue.\nThe biopharmaceutical company reported that its revenue for FY2025 dropped 90.9% to just RMB 3.5 million, primarily due to the termination of AdimFlu-S commercial activities in mainland China. The remaining revenue reflects a return-rate true-up on prior-period sales.\nWhile the company's loss for the year narrowed by 77.3% to RMB 205.1 million, investors appeared focused on the severe revenue contraction and the 51.23% decline in cash and bank balances to RMB 271.4 million, attributed to bank-loan repayment, continued R&D investment, and daily operations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1196931301","isCrawlerRequest":true}